Ritivel YC 申请

Winter 2026Active

Ritivel 在 Winter 2026 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Winter 2026
行业: HealthcareHealthcare IT
团队规模: 3
状态: Active
已发布: 2026

创始人

Nirmit AroraFounder
Gunin GuptaFounder
Pavan Kalyan (a.k.a PK) TankalaFounder

Ritivel 做什么

Ritivel is an AI-native workspace for regulatory and medical writing teams at life sciences companies. Our AI agents draft CTDs, CSRs, INDs, and BLAs in minutes instead of weeks, helping drugs reach patients faster. Every month a drug is delayed from reaching the market costs pharma companies ~$45M in lost revenue and more importantly, delays treatment for thousands of patients who need it. Yet regulatory teams are stuck in a painful, months-long process: synthesizing thousands of pages of clinical data, hunting through SharePoint folders for the right documents, chasing colleagues for missing inputs, and manually drafting submissions. Ritivel deploys AI agents that transform how regulatory teams work. Our agents generate comprehensive first drafts directly in Microsoft Word, following FDA formatting requirements and pulling from your existing clinical data and prior submissions. Every data point includes citations linked back to the original source, so reviewers can verify with one click. Connected to SharePoint and Veeva, our agents automatically source the right documents. Integrated with Outlook, they handle reminder emails and follow-ups automatically. We're engineers who previously built AI copilots at Microsoft Research. After 50+ conversations with pharma professionals, we discovered the critical bottleneck in regulatory submissions and built Ritivel to solve it.

Ritivel 的 YC 申请，重建版

Y Combinator 申请

Ritivel，Winter 2026 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Ritivel

Describe what your company does in 50 characters or less.

AI-native platform for Life-Sciences Documentation

What is your company going to make? Please describe your product and what it does or will do.

We built an AI-native workspace specifically for regulatory and medical writing teams in life sciences. Our AI agents generate first drafts of CTDs, CSRs, INDs, and BLAs within minutes, following FDA formatting and citing original data sources. They integrate with SharePoint, Veeva, and Outlook to pull documents, automate follow-ups, and simplify weeks-long manual processes into a matter of hours.

Where do you live now, and where would the company be based after YC?

We live in San Francisco and plan to keep the company based here after YC as well.

Explain your decision regarding location.

San Francisco is where we live and where our target enterprise clients and partners are concentrated. Being here keeps us close to pharma and biotech hubs and lets us recruit the talent we need to build complex AI tools for regulatory documentation.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Ritivel 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Ritivel 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Ritivel 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Ritivel 是哪个 YC 批次的？

Ritivel 是 Y Combinator Winter 2026 批次的成员。

谁创立了 Ritivel？

Ritivel 由 Nirmit Arora, Gunin Gupta, Pavan Kalyan (a.k.a PK) Tankala 创立。

Ritivel 做什么？